In the rapidly advancing life science fields, endpoint polymerase chain reaction (PCR), real-time PCR (qPCR), and digital PCR (dPCR) have become indispensable tools that complement one another across a variety of applications. These three PCR technologies each offer unique strengths and capabilities that make them essential for modern research. These PCR technologies are complementary, each contributing critical value depending on the research needs at hand.
Endpoint PCR continues to be a reliable, straightforward method for qualitative analysis, offering cost-effective solutions for amplifying or detecting the presence of specific genes. Real-time PCR adds quantitative power, allowing researchers to measure gene expression levels with precision and speed. Zooming in even further, digital PCR provides absolute quantification, enabling researchers to detect low-abundance targets and rare genetic variations with unparalleled sensitivity and accuracy.
This eBook will guide you through a more detailed look into the advantages of each PCR technology and explain how they are applied independently and in concerted workflows with gene expression analysis serving as a focal point example.
Readers will gain a practical understanding of how endpoint PCR supports qualitative detection and initial screening, how qPCR enables dynamic and reproducible relative quantification through amplification curve analysis and cycle threshold (Ct) values, and how dPCR delivers absolute quantification via thousands of micro-reactions for high-sensitivity detection.
The guide also emphasizes the critical role of sample preparation, including RNA extraction, DNase treatment, reverse transcription to cDNA, and inhibitor removal, all key steps that influence accuracy and reproducibility across all PCR methods
Whether conducting basic research or addressing complex applied challenges, understanding how these modern PCR techniques complement each other will empower you to make informed decisions, optimize your experimental design, and push the boundaries of scientific discovery and productivity.
You're almost there!
Fill out the form below to get permanent access to this free article.
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.
